🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,557 results for “placebo” Clear

  1. Placebo

    Alnylam Netherlands B.V.

    IgA Nephropathy (IgAN)

    phase 2 small molecule terminated

    1 trial

  2. Placebo

    Biotech Pharmaceutical Co.,

    Hemophilic Arthropathy

    phase 2 small molecule completed

    1 trial

  3. Placebo

    Advanz Pharma Limited

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

  4. Placebo

    Janssen Cilag International NV

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  5. Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  6. Placebo

    Regeneron UK Limited

    Asthma

    phase 2 small molecule completed

    1 trial

  7. Placebo

    Regeneron UK Limited

    Generalized Lipodystrophy

    phase 2 small molecule completed

    1 trial

  8. Placebo

    MedImmune

    Asthma

    phase 2 small molecule completed

    1 trial

  9. Placebo

    Takeda

    Gout

    phase 2 small molecule completed

    1 trial

  10. Placebo

    Takeda

    Graft Rejection

    phase 2 mab completed

    1 trial

  11. Placebo

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial

  12. Placebo

    Takeda

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

  13. Placebo

    Hospital Authority, Hong Kong

    STOMACH NEOPLASM

    phase 2 small molecule active

    1 trial

  14. Placebo

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule completed

    1 trial

  15. Placebo

    Takeda

    Primary Immune Thrombocytopenia

    phase 2 small molecule completed

    1 trial

  16. Placebo

    Takeda

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  17. Placebo

    Hoffmann-La Roche

    Diabetes Mellitus Type 2

    phase 2 small molecule completed

    1 trial

  18. Placebo

    WINDTREE THERAPEUTICS INC /DE/

    Acute Decompensated Heart Failure

    phase 2 small molecule completed

    1 trial

  19. Placebo

    Universal Integrated

    Purpura, Schoenlein-Henoch

    phase 2 small molecule active

    1 trial

  20. Placebo

    Teva Pharma GmbH

    Primary Progressive Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  21. Placebo

    Vistagen Therapeutics

    Healthy

    phase 2 small molecule completed

    1 trial

  22. Placebo

    Alnylam Netherlands B.V.

    Hypertension

    phase 2 small molecule completed

    1 trial

  23. Placebo

    Serono Europe Limited

    Systemic Lupus Erythematosus

    phase 2 small molecule terminated

    1 trial

  24. Placebo

    Cardiff Oncology

    Tuberous Sclerosis

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources